SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

11/14/24 1:22:35 PM ET

Medical/Dental Instruments

Health Care

Get the next $XRAY alert in real time by email

SC 13G 1 xray13gsep24.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) DENTSPLY SIRONA INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 24906P109 (CUSIP NUMBER) September 30, 2024 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. ROWE PRICE ASSOCIATES, INC. 52-0556948 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 10,537,486 6. Shared Voting Power* 0 7. Sole Dispositive Power* 10,573,838 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 10,573,838 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 5.2% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: DENTSPLY SIRONA INC Item 1(b) Address of Issuer's Principal Executive Offices: 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC 28277-3607 Item 2(a) Name of Person(s) Filing: (1) T. ROWE PRICE ASSOCIATES, INC. (Price Associates) Item 2(b) Address of Principal Business Office: 100 E. Pratt Street, Baltimore, MD 21202 Item 2(c) Citizenship or Place of Organization: (1) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 24906P109 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class Not Applicable Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Associates does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Associates serves as investment adviser. Any and all discretionary authority which has been delegated to Price Associates may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Associates which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Associates. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. ROWE PRICE ASSOCIATES, INC. Date: November 14, 2024 Signature: /s/ Ellen York Name & Title: Ellen York, Vice President 09/30/2024

Get the next $XRAY alert in real time by email

Recent Analyst Ratings for

$XRAY

Date	Price Target	Rating	Analyst
4/15/2025	$14.00	Overweight → Equal-Weight	Morgan Stanley
3/13/2025		Buy → Hold	Needham
2/14/2025	$20.00	Equal Weight	Wells Fargo
1/23/2025	$30.00 → $20.00	Buy → Hold	Jefferies
1/7/2025	$20.00	Outperform → In-line	Evercore ISI
12/4/2024	$21.00	Neutral	Mizuho
11/7/2024		Outperform → Market Perform	Leerink Partners
10/25/2024	$34.00 → $29.00	Buy	Needham

More analyst ratings

SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

Chat with this insight

Recent Analyst Ratings for $XRAY

$XRAY Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Vergis Janet S. was granted 87 shares, increasing direct ownership by 0.29% to 30,101 units (SEC Form 4)

Director Varon Leslie F was granted 87 shares, increasing direct ownership by 0.26% to 33,807 units (SEC Form 4)

EVP, Corp Dev, GC & Secretary Rosenzweig Richard C was granted 628 shares, increasing direct ownership by 0.76% to 83,452 units (SEC Form 4)

$XRAY SEC Filings

$XRAY Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

$XRAY Large Ownership Changes

This live feed shows all institutional transactions in real time.

$XRAY Financials

Live finance-specific insights

SEC Form 10-Q filed by DENTSPLY SIRONA Inc.

DENTSPLY SIRONA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

SEC Form DEFA14A filed by DENTSPLY SIRONA Inc.

Director Lucier Gregory T bought $249,994 worth of shares (15,142 units at $16.51), increasing direct ownership by 23% to 81,971 units (SEC Form 4)

Amendment: Director Lucier Gregory T bought $110,129 worth of shares (6,000 units at $18.35), increasing direct ownership by 8% to 66,730 units (SEC Form 4)

Director Lucier Gregory T bought $110,129 worth of shares (6,000 units at $18.35), increasing direct ownership by 7% to 71,730 units (SEC Form 4)

Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.

SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

Dentsply Sirona Reports First Quarter 2025 Results

Dentsply Sirona to Host First Quarter Conference Call on May 8th

Dentsply Sirona Reports Fourth Quarter and Full Year 2024 Results, Provides Full Year 2025 Outlook

$XRAY Press Releases

Fastest customizable press release news feed in the world

Dentsply Sirona Reports First Quarter 2025 Results

Dentsply Sirona to Host First Quarter Conference Call on May 8th

Dentsply Sirona Appoints David Ferguson as Global Business Unit Leader

$XRAY Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Dentsply Sirona downgraded by Morgan Stanley with a new price target

Dentsply Sirona downgraded by Needham

Wells Fargo initiated coverage on Dentsply Sirona with a new price target

$XRAY Leadership Updates

Live Leadership Updates

Dentsply Sirona Appoints David Ferguson as Global Business Unit Leader

Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members

Dentsply Sirona Appoints Herman V. Cueto Interim Chief Financial Officer

Recent Analyst Ratings for
$XRAY

$XRAY
Insider Trading

$XRAY
SEC Filings

$XRAY
Insider Purchases

$XRAY
Large Ownership Changes

$XRAY
Financials

$XRAY
Press Releases

$XRAY
Analyst Ratings

$XRAY
Leadership Updates